These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23013706)

  • 1. Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in Chinese valve replacement patients.
    Li JH; Ma GG; Zhu SQ; Yan H; Wu YB; Xu JJ
    J Cardiothorac Surg; 2012 Sep; 7():97. PubMed ID: 23013706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
    An SH; Chang BC; Lee KE; Gwak HS
    Cardiovasc Ther; 2015 Dec; 33(6):324-8. PubMed ID: 26223945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
    Li J; Yang W; Xie Z; Yu K; Chen Y; Cui K
    BMC Cardiovasc Disord; 2018 May; 18(1):96. PubMed ID: 29776386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients.
    Singh O; Sandanaraj E; Subramanian K; Lee LH; Chowbay B
    Drug Metab Pharmacokinet; 2011; 26(2):130-6. PubMed ID: 21084764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gene polymorphims on the warfarin treatment at initial stage.
    Liu J; Jiang HH; Wu DK; Zhou YX; Ye HM; Li X; Luo ZY; Guo Z; Zhang YL; Wang YC; Zhang W; Zhou HH; Wang LS
    Pharmacogenomics J; 2017 Jan; 17(1):47-52. PubMed ID: 26644206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CYP4F2 gene polymorphisms on warfarin clearance and sensitivity in Korean patients with mechanical cardiac valves.
    Lee KE; Chang BC; Kim HO; Yoon IK; Lee NR; Park HY; Gwak HS
    Ther Drug Monit; 2012 Jun; 34(3):275-82. PubMed ID: 22549502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area].
    Zhuang W; Wu D; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):13-7. PubMed ID: 24602724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin.
    Ma C; Zhang Y; Xu Q; Yang J; Zhang Y; Gao L; Xu B; Wang H; Li Y; Lu C; Yin T
    Int J Hematol; 2012 Dec; 96(6):719-28. PubMed ID: 23104259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.
    Borgiani P; Ciccacci C; Forte V; Sirianni E; Novelli L; Bramanti P; Novelli G
    Pharmacogenomics; 2009 Feb; 10(2):261-6. PubMed ID: 19207028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis.
    Liang R; Wang C; Zhao H; Huang J; Hu D; Sun Y
    Thromb Res; 2012 Jul; 130(1):38-44. PubMed ID: 22192158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of genetic factors (CYP2C9, VKORC1 and CYP4F2) on warfarin dose requirement in the Turkish population.
    Özer M; Demirci Y; Hizel C; Sarikaya S; Karalti İ; Kaspar Ç; Alpan S; Genç E
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):209-14. PubMed ID: 23061746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.
    McDonald MG; Rieder MJ; Nakano M; Hsia CK; Rettie AE
    Mol Pharmacol; 2009 Jun; 75(6):1337-46. PubMed ID: 19297519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP4F2 1347 G > A & GGCX 12970 C > G polymorphisms: frequency in north Indians & their effect on dosing of acenocoumarol oral anticoagulant.
    Rathore SS; Agarwal SK; Pande S; Singh SK; Mittal T; Mittal B
    Indian J Med Res; 2014 Apr; 139(4):572-8. PubMed ID: 24927344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of NR3C1 and VDR polymorphisms on stable warfarin dose in patients with mechanical cardiac valves.
    Lee KE; Chung JE; Yi B; Cho YJ; Kim HJ; Lee GY; Kim JH; Chang BC; Gwak HS
    Int J Cardiol; 2017 Jun; 236():393-397. PubMed ID: 28262345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study.
    Bejarano-Achache I; Levy L; Mlynarsky L; Bialer M; Muszkat M; Caraco Y
    Clin Ther; 2012 Apr; 34(4):811-23. PubMed ID: 22417713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.
    Shendre A; Brown TM; Liu N; Hill CE; Beasley TM; Nickerson DA; Limdi NA
    Pharmacotherapy; 2016 Mar; 36(3):263-72. PubMed ID: 26877068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy.
    Zhang JE; Jorgensen AL; Alfirevic A; Williamson PR; Toh CH; Park BK; Pirmohamed M
    Pharmacogenet Genomics; 2009 Oct; 19(10):781-9. PubMed ID: 19741565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement.
    Liu R; Cao J; Zhang Q; Shi XM; Pan XD; Dong R
    Medicine (Baltimore); 2017 Jan; 96(2):e5658. PubMed ID: 28079798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CYP4F2 rs2108622 on the stable warfarin dose in an admixed patient cohort.
    Perini JA; Struchiner CJ; Silva-Assunção E; Suarez-Kurtz G
    Clin Pharmacol Ther; 2010 Apr; 87(4):417-20. PubMed ID: 20182420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of genetic and clinical factors on warfarin therapy in patients early after heart valve replacement surgery.
    Li B; Liu R; Wang C; Ren C; Zhang S; Zhang F; Zhang J; Liu S; Wei Y; Liu W; Song B; Wu X
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1685-1693. PubMed ID: 31444512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.